Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. BioPharma Credit PLC
  6. News
  7. Summary
    BPCR   GB00BDGKMY29

BIOPHARMA CREDIT PLC

(BPCR)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Biopharma Credit : Halts Trading On International Exchange Authority

10/08/2021 | 02:35am EST


ę MT Newswires 2021
All news about BIOPHARMA CREDIT PLC
11/04BioPharma Credit PLC Declares Interim Dividend for the Period Ended September 30, 2021,..
CI
10/08BIOPHARMA CREDIT : Halts Trading On International Exchange Authority
MT
10/05BIOPHARMA CREDIT : Begins Trading On LSE's Premium Segment
MT
09/15BIOPHARMA CREDIT : Logs Higher H1 Return On Ordinary Activities Amid Net Income Growth
MT
09/15BIOPHARMA CREDIT : Earnings Flash (BPCR.L) BIOPHARMA CREDIT Reports H1 Revenue $74.7M
MT
09/15Biopharma Credit plc Reports Earnings Results for the Half Year Ended June 30, 2021
CI
09/13Biopharma Credit PLC Enters into an Amendment to the Credit Facility
CI
09/10FTSE 100 Inches Higher on Rebound in Basic Resources, Industrials
DJ
09/10FTSE Gains, Pound Expected to Fall Against Euro in 2022 on UK Rate Rise Delay, Brexit R..
DJ
09/10FTSE 100 Gains, Sterling Rises on Prospect of BOE Tightening
DJ
More news
Financials (USD)
Sales 2020 110 M - -
Net income 2020 89,1 M - -
Net cash 2020 193 M - -
P/E ratio 2020 15,4x
Yield 2020 7,03%
Capitalization 1 311 M 1 311 M -
EV / Sales 2019 7,32x
EV / Sales 2020 10,7x
Nbr of Employees -
Free-Float 87,7%
Chart BIOPHARMA CREDIT PLC
Duration : Period :
BioPharma Credit PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOPHARMA CREDIT PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 0,95 
Average target price
Spread / Average Target -
Managers and Directors
Duncan William Allan Budge Independent Non-Executive Director
Colin Bond Independent Non-Executive Director
Harry Abraham Hyman Senior Independent Director
Rolf Kristian Soderstrom Non-Executive Director
Sector and Competitors